Essential Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Essential Partners's PFE Position: Q2 2026 in Review
Essential Partners increased its Pfizer (PFE) stake by 131% in Q2 2026, buying an estimated $150K and bringing the position to 10,101 shares worth $243K. The position accounts for 0.11% of the portfolio, ranked #196.
Essential Partners first reported a position in PFE in Q2 2025 and has held it in 5 quarters since. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Essential Partners held 10,101 shares of Pfizer worth $243K as of Q2 2026.
- Essential Partners bought 5,720 Pfizer shares in Q2 2026, an estimated $150K.
- Pfizer made up 0.11% of Essential Partners's portfolio in Q2 2026, its #196 holding.
- Essential Partners first reported a position in Pfizer in Q2 2025 and has held it in 5 quarters since.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.